Tuberculosis (TB) medication can cause short-term side effects, such as loss of appetite, fever, and fatigue. Long-term side effects can include lung dysfunction and issues with the digestive system.

Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with potential to replace this current cornerstone in ...